China’s dominance is reflected not only in patent numbers but also in the diverse application of nanotech across multiple sectors. Beijing, Shanghai, Shenzhen, and Suzhou lead efforts in semiconductor ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate MAIA Biotechnology, Inc. before investing. In this article, we go over a few key ...

RALEIGH, N.C. (WTVD) -- With so much uncertainty in the job market, along with concerns about funding for higher education, Wake Tech is actually experiencing explosive growth. The school's president ...

George is a professor of genetics at Harvard Medical School and professor of health sciences and technology at Harvard and MIT. He is a prolific researcher studying genetic sequencing, genome editing, ...

The Age of AI will rely on massive volumes of data that can be easily stored and retrieved—and bioscience may have an ingenious solution. A scientist examines a DNA (deoxyribonucleic acid) profile on ...

Oklahoma's sophomore U.S. Rep. Stephanie Bice says the state can play an important role in the biotechnology industry as the state continues to be a leader in innovation. The Republican representative ...

OKLAHOMA CITY — Oklahoma is a “blueprint” for Washington, D.C. of how to implement public-private partnerships in biotechnology, said a federal official who has been tasked with reviewing advancements ...

The U.S. startup IPO market is coming back to life. Unless, that is, you’re a biotech company. So far this year, just 16 funded U.S. startups in the biotech, drug discovery and medical device spaces ...

Ancient events in plant evolution have left behind large, duplicated regions in their genomes. Salk Institute scientists found that deleting these large blocks of DNA can still lead to normal plants.

RAIN Incubator in Tacoma closed in 2024 as a result of financial struggles. Leadership cited state funding shifts and challenge of maintaining stream of viable startups for incubator as key issues.

Aug 11 (Reuters) - IO Biotech (IOBT.O), opens new tab said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's progression in a late-stage study, but ...